Overview of the Haematological effects of COVID19 infection
dc.citation.doi | 10.1007/978-3-303-59261-5 | |
dc.citation.epage | 173 | |
dc.citation.spage | 163 | |
dc.contributor.author | Wiggill, Tracey M. | |
dc.contributor.author | Mayne, Elizabeth S. | |
dc.contributor.author | Vaughan, Jenifer L. | |
dc.contributor.author | Louw, Susan | |
dc.date.accessioned | 2023-02-28T09:37:56Z | |
dc.date.available | 2023-02-28T09:37:56Z | |
dc.department | Molecular Medicine and Haematology | |
dc.description.abstract | From its early origins, COVID-19 has spread extensively and was declared a global pandemic by the World Health Organization in March of 2020. Although initially thought to be predominantly a respiratory infection, more recent evidence points to a multisystem systemic disease which is associated with numerous haematological and immunological disturbances in addition to its other effects. Here we review the current knowledge on the haematological effects of COVID-19. | |
dc.faculty | Faculty of Health Sciences | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 0065-2598 | |
dc.identifier.uri | https://hdl.handle.net/10539/34706 | |
dc.journal.title | Advances in experimental medicine and biology | |
dc.journal.volume | 1321 | |
dc.rights | © The Author(s), under exclusive license to Springer Nature 163 Switzerland AG 2021 | |
dc.school | School of Pathology | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.subject | Pandemic | |
dc.subject | Haematology | |
dc.subject | Immunology | |
dc.subject | Human immuno deficiency virus | |
dc.subject | Tuberculosis | |
dc.subject.other | SDG-3: Good health and well-being | |
dc.title | Overview of the Haematological effects of COVID19 infection |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal.pdf
- Size:
- 295.21 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal